# Venceslau Hespanhol

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/venceslau-hespanhol/

## Facts

| Field | Value |
| --- | --- |
| Citations | 5,278 |
| Field | Lung Cancer Treatments and Mutations |
| h-index | 27 |
| i10-index | 54 |
| Last Known Institution | Universidade do Porto |
| OpenAlex ID | https://openalex.org/A5035060250 |
| ORCID iD | 0000-0001-6577-0063 |
| Works | 200 |

## Researcher papers

- [Pembrolizumab versus chemotherapy for previously untreated, PD-L1-expressing, locally advanced or metastatic non-small-cell lung cancer (KEYNOTE-042): a randomised, open-label, controlled, phase 3 trial](https://scholariq.org/papers/pembrolizumab-versus-chemotherapy-for-previously-untreated-pd-l1-expressing/)
- [Pneumonia mortality, comorbidities matter?](https://scholariq.org/papers/pneumonia-mortality-comorbidities-matter/)
- [The Role of Liquid Biopsy in Early Diagnosis of Lung Cancer](https://scholariq.org/papers/the-role-of-liquid-biopsy-in-early-diagnosis-of-lung-cancer/)
- [Survival predictors in advanced non-small cell lung cancer](https://scholariq.org/papers/survival-predictors-in-advanced-non-small-cell-lung-cancer/)
- [<p>COPD: misuse of inhaler devices in clinical practice</p>](https://scholariq.org/papers/and-lt-p-and-gt-copd-misuse-of-inhaler-devices-in-clinical-practice-and-lt-p-and/)
- [COPD: understanding patients’ adherence to inhaled medications](https://scholariq.org/papers/copd-understanding-patients-and-amp-rsquo-adherence-to-inhaled-medications/)
- [Identifying relationships between imaging phenotypes and lung cancer-related mutation status: EGFR and KRAS](https://scholariq.org/papers/identifying-relationships-between-imaging-phenotypes-and-lung-cancer-related/)
- [Sharing Biomedical Data: Strengthening AI Development in Healthcare](https://scholariq.org/papers/sharing-biomedical-data-strengthening-ai-development-in-healthcare/)
- [Management of infusion-related reactions in cancer therapy: strategies and challenges](https://scholariq.org/papers/management-of-infusion-related-reactions-in-cancer-therapy-strategies-and/)
- [<i>EGFR</i> Assessment in Lung Cancer CT Images: Analysis of Local and Holistic Regions of Interest Using Deep Unsupervised Transfer Learning](https://scholariq.org/papers/i-egfr-i-assessment-in-lung-cancer-ct-images-analysis-of-local-and-holistic/)
- [Resistance Profile of Osimertinib in Pre-treated Patients With EGFR T790M-Mutated Non-small Cell Lung Cancer](https://scholariq.org/papers/resistance-profile-of-osimertinib-in-pre-treated-patients-with-egfr-t790m/)
- [Progression after osimertinib in EGFR T790M-mutated non-small cell cancer patients](https://scholariq.org/papers/progression-after-osimertinib-in-egfr-t790m-mutated-non-small-cell-cancer/)

## Researcher topics

- [Lung Cancer Treatments and Mutations](https://scholariq.org/topics/lung-cancer-treatments-and-mutations/)
- [Lung Cancer Diagnosis and Treatment](https://scholariq.org/topics/lung-cancer-diagnosis-and-treatment/)
- [Chronic Obstructive Pulmonary Disease (COPD) Research](https://scholariq.org/topics/chronic-obstructive-pulmonary-disease-copd-research/)
- [Cancer Genomics and Diagnostics](https://scholariq.org/topics/cancer-genomics-and-diagnostics/)
- [Radiomics and Machine Learning in Medical Imaging](https://scholariq.org/topics/radiomics-and-machine-learning-in-medical-imaging/)

## Researcher university

- [Universidade do Porto](https://scholariq.org/institutions/universidade-do-porto/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.